NAPROXEN
- Product NDC
- 61919-586
- 11-digit product format
- 619190586
- Labeler code
- 61919
- Product ID
- 61919-586_9ca985c6-503e-0558-e053-2995a90a8202
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA091305
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-586-14 | NAPROXEN | 14 in 1 BOTTLE | TABLET | 14 | | 4 |
| 61919-586-20 | NAPROXEN | 20 in 1 BOTTLE | TABLET | 20 | | 4 |
| 61919-586-60 | NAPROXEN | 60 in 1 BOTTLE | TABLET | 60 | | 4 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-586 | NAPROXEN TABLET [DIRECTRX] | 4 | Legacy NDC, 3 package rows | 20200130_50c696da-0ea6-4d76-b50e-fb0b55ff77ae.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-586-14 | 61919058614 | 14 TABLET in 1 BOTTLE (61919-586-14) | 14 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |
| 61919-586-20 | 61919058620 | 20 TABLET in 1 BOTTLE (61919-586-20) | 20 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |
| 61919-586-60 | 61919058660 | 60 TABLET in 1 BOTTLE (61919-586-60) | 60 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |